Search results for "2 diabetes"

showing 10 items of 679 documents

Does chronic pain hinder physical activity among older adults with type 2 diabetes?

2021

Background: Physical activity (PA) is a key component in management of type 2 diabetes (T2D). Pain might be a barrier to PA especially among older adults with T2D, but surprisingly few studies have investigated the association between chronic pain and PA. Our aim was to evaluate the prevalence of chronic pain among older adults with T2D and to examine the association between chronic pain and PA while taking important life-contextual factors into account. Methods: Data of this register-based, cross-sectional study were collected in a survey among adults with T2D (n=2866). In the current study, only respondents aged 65–75 years were included (response rate 63%, n=1386). Data were analysed by …

medicine.medical_specialtyHealth (social science)media_common.quotation_subjectPhysical activityphysical activityType 2 diabetesNursingLogistic regressionPerceived health03 medical and health sciencesBehavioral Neuroscience0302 clinical medicinemedicineSevere paint2dPsychologyT2D030212 general & internal medicineGeneral Psychologyolder adultsmedia_commonResponse rate (survey)030505 public healthdiabetesbusiness.industryOmvårdnadChronic painRPublic Health Global Health Social Medicine and EpidemiologyArticlesmedicine.diseaseBF1-990Folkhälsovetenskap global hälsa socialmedicin och epidemiologiFeelingPhysical therapykrooninen kipuMedicine0305 other medical sciencebusinesschronic painaikuistyypin diabetesfyysinen aktiivisuusikääntyneetResearch Article
researchProduct

Steatohepatitis and type 2 diabetes mellitus are influenced by genetic susceptibility to increased intestinal permeability in patients with non-alcoh…

2017

medicine.medical_specialtyIntestinal permeabilityHepatologybusiness.industrySettore MED/12 - GASTROENTEROLOGIAFatty liverGastroenterologyType 2 Diabetes MellitusNon alcoholicDiseasemedicine.diseaseGastroenterologyN/AInternal medicinemedicineGenetic predispositionIn patientSteatohepatitisbusinessDigestive and Liver Disease
researchProduct

Association of ACACB polymorphisms with obesity and diabetes

2011

El pdf del artículo es la versión pre-print.-- et al.

medicine.medical_specialtyLinkage disequilibriumEndocrinology Diabetes and MetabolismPopulationSingle-nucleotide polymorphismType 2 diabetesBiologyBiochemistryPolymorphism Single NucleotideLinkage DisequilibriumCohort StudiesEndocrinologyInternal medicineGeneticsmedicineHumansObesityAlleleeducationMolecular BiologyAllelesGenetic Association StudiesAgedGeneticsACACBAged 80 and overeducation.field_of_studyHaplotypeAcetyl-CoA carboxylaseType 2 diabetesMiddle Agedmedicine.diseasePostmenopauseEndocrinologyDiabetes Mellitus Type 2HaplotypesACACBCase-Control StudiesFemalePolymorphismsAcetyl-CoA Carboxylase
researchProduct

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans

2008

Blood concentrations of lipoproteins and lipids are heritable1 risk factors for cardiovascular disease2,3. Using genome-wide association data from three studies (n = 8,816 that included 2,758 individuals from the Diabetes Genetics Initiative specific to the current paper as well as 1,874 individuals from the FUSION study of type 2 diabetes and 4,184 individuals from the SardiNIA study of aging-associated variables reported in a companion paper in this issue4) and targeted replication association analyses in up to 18,554 independent participants, we show that common SNPs at 18 loci are reproducibly associated with concentrations of low-density lipoprotein (LDL) cholesterol, high-density lipo…

medicine.medical_specialtyLinkage disequilibriumSingle-nucleotide polymorphismType 2 diabetes030204 cardiovascular system & hematologyBiologyArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicineHigh-density lipoproteinInternal medicineDiabetes mellitusGeneticsmedicine030304 developmental biologyGenetics0303 health sciencesTriglycerideCholesterolmedicine.disease3. Good healthEndocrinologychemistrylipids (amino acids peptides and proteins)Lipoprotein
researchProduct

Incretin-Based Therapies, Glucometabolic Health and Endovascular Inflammation

2013

Incretin peptides are a group of gastrointestinal hormones that play a prominent role in the regulation of glucose metabolism. Incretin-based therapies (IBTs) have recently emerged as an important treatment option for patients with type 2 diabetes mellitus (T2DM). These pharmaceutical agents may be specially well suited for patients who are overweight or obese with primarily post-meal glucose peaks, and in whom traditional first-line oral agents have failed to maintain adequate glycemic control. There are 2 classes of IBTs: the dipeptidyl peptidase-4 (DPP-4) inhibitors and the glucagon-like peptide 1 (GLP-1) receptor agonists. The ultimate effect of both types of agents is to augment GLP-1 …

medicine.medical_specialtyLipoproteinsIncretin type 2 diabetes mellitus metabolic syndrome lipoproteinsIncretinBiologyIncretinsGlucagon-Like Peptide-1 ReceptorWeight lossDiabetes mellitusInternal medicineDrug DiscoverymedicineAnimalsHumansGlucose homeostasisAdiponectin secretionLipoproteinInflammationPharmacologyDipeptidyl-Peptidase IV InhibitorsDrug Discovery3003 Pharmaceutical ScienceMedicine (all)digestive oral and skin physiologyGlucagon secretionType 2 Diabetes MellitusIncretinAtherosclerosismedicine.diseaseMetabolic syndromeType 2 diabetes mellituGlucoseEndocrinologyDiabetes Mellitus Type 2Metabolic syndromemedicine.symptomCurrent Pharmaceutical Design
researchProduct

Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance.

2004

Type 2 diabetes is an important cardiovascular risk factor. A significant component of the risk associated with type 2 diabetes is thought to be because of its characteristic lipid "triad" profile of raised small dense low-density lipoprotein levels, lowered high-density lipoprotein, and elevated triglycerides (TGs). Trials of statins and fibrates have included substantial numbers of patients with diabetes and indicate that lipid lowering reduces cardiovascular event rates in these patients. However, statins alone do not always address all the lipid abnormalities of diabetes. Fibrates, which have low affinity for peroxisome proliferator-activated receptor alpha (PPARalpha), improve most asp…

medicine.medical_specialtyLipoproteinsPeroxisome proliferator-activated receptorType 2 diabetesInsulin resistanceRisk FactorsInternal medicineDiabetes mellitusmedicineLipolysisHumansPPAR alphaDyslipidemiaschemistry.chemical_classificationbusiness.industrynutritional and metabolic diseasesLipid metabolismmedicine.diseaseLipid MetabolismEndocrinologychemistryDiabetes Mellitus Type 2Cardiovascular Diseaseslipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessDyslipidemiaLipoproteinAmerican heart journal
researchProduct

Positive Airway Pressure Treatment Reduces Glycated Hemoglobin (HbA1c) Levels in Obstructive Sleep Apnea Patients: Longitudinal Data from the Esada

2019

European-Respiratory-Society (ERS) International Congress -- SEP 28-OCT 02, 2019 -- Madrid, SPAIN

medicine.medical_specialtyLongitudinal dataGastroenterologyComorbidities03 medical and health sciencesHba1c levelchemistry.chemical_compound0302 clinical medicineDiabetes mellitusInternal medicinePositive airway pressuremedicine030212 general & internal medicinebusiness.industryType 2 Diabetes MellitusSleep apneaSystemic effectmedicine.diseaserespiratory tract diseasesObstructive sleep apnea030228 respiratory systemApnea–hypopnea indexchemistryCardiologyGlycated hemoglobinbusinessBody mass indexTurkish Thoracic Journal
researchProduct

Periodontal disease and diabetes : review of the literature

2010

Aims: To provide updated knowledge on the relationship between periodontal disease and diabetes from an oral health perspective. Methods: A review of the English-language literature was performed, gathering articles on the two diseases published over the past 10 years. Results: Both diseases result from the confluence of various triggering and modifying factors, and there are inter-individual differences in the risk of their development. Recent research has shown that diabetes may increase the risk of periodontitis, and it has been proposed that chronic periodontal disease may influence the natural course of diabetes. There appears to be an association among oral infections, impaired sugar …

medicine.medical_specialtyMEDLINEDentistryType 2 diabetesDiabetes Complications03 medical and health sciences0302 clinical medicinePeriodontal diseaseDiabetes mellitusmedicineHumans030212 general & internal medicineIntensive care medicineGeneral DentistryPeriodontal DiseasesGlycemicPeriodontitisNatural coursebusiness.industry030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]3. Good healthDiabetes Mellitus Type 2OtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryMetabolic syndromebusiness
researchProduct

Magnesium metabolism in hypertension and type 2 diabetes mellitus.

2007

The increasing evidence for the clinical relevance of altered magnesium metabolism to states of altered insulin resistance confirms the role of magnesium deficit as a possible underlying common mechanism of the "insulin resistance" of hypertension and altered glucose tolerance. The pioneer work of Lawrence M. Resnick and his group using the cellular ion-based approach that we are only partially presenting here has consistently contributed to the progress of the field, demonstrating (a) the critical importance of magnesium metabolism in regulating insulin sensitivity as well as vascular tone, and blood-pressure homeostasis; (b) that magnesium deficiency, defined on the basis of intracellular…

medicine.medical_specialtyMagnetic Resonance Spectroscopychemistry.chemical_elementEssential hypertensionInsulin resistancePre-EclampsiaPregnancyMagnesium deficiency (medicine)Diabetes mellitusInternal medicinemedicineHumansPharmacology (medical)MagnesiumSodium Chloride DietaryPharmacologyCalcium metabolismMagnesiumbusiness.industryType 2 Diabetes MellitusGeneral MedicineSyndromemedicine.diseaseEndocrinologychemistryDiabetes Mellitus Type 2HypertensionCalciumFemaleInsulin ResistancebusinessMagnesium DeficiencyHomeostasisAmerican journal of therapeutics
researchProduct

Sodium-glucose cotransporter 2 inhibition : towards an indication to treat diabetic kidney disease

2020

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have clearly demonstrated their beneficial effect in diabetic kidney disease (DKD) on top of the standard of care [blood glucose control, renin–angiotensin system blockade, smoking cessation and blood pressure (BP) control], even in patients with overt DKD. However, the indication of this drug class is still blood glucose lowering in type 2 diabetic patients with estimated glomerular filtration rate >45mL/min/1.73m2. Based on the new evidence, several scientific societies have emphasized the preferential prescription of SGLT2i for patients at risk of heart failure or kidney disease, but still within the limits set by health authorities. A r…

medicine.medical_specialtyMedicina030232 urology & nephrologyRenal functionReviewsType 2 diabetes030204 cardiovascular system & hematologyDiabetic nephropathy03 medical and health sciences0302 clinical medicineSodium-Glucose Transporter 2Internal medicineDiabetes mellitusDiabetic nephropathiesmedicineChronic renal failureHumansDiabetic NephropathiesDiabetic kidney diseaseESRDSodium-Glucose Transporter 2 InhibitorsTransplantationbusiness.industryType 2 diabetesNefropaties diabètiquesmedicine.diseasePrognosisBlood pressureDiabetes Mellitus Type 2NephrologyHeart failureSodium/Glucose Cotransporter 2Insuficiència renal crònicabusinessSGLT2 inhibitorsKidney disease
researchProduct